Ligand profile
E4O
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_0276 — threonine--tRNA ligase
Identifiers
Database identifiers and provenance.
- Ligand ID
E4O- PDB
6l2q- UniProt (similar protein)
V7II86- Target protein
- VK055_0276
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 110.2
- −1 ≤ LogP ≤ 5 1.08
- MW ≤ 500 Da 385.3
- LogP ≤ 5 1.08
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 6
- TPSA ≤ 140 Ų 110.2
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C[C@H]([C@@H](C(=O)NC/C=C/CN1C=Nc2cc(c(cc2C1=O)Cl)Cl)N)OC[C@H]([C@@H](C(=O)NC/C=C/CN1C=Nc2cc(c(cc2C1=O)Cl)Cl)N)O
InChI=1S/C16H18Cl2N4O3/c1-9(23)14(19)15(24)20-4-2-3-5-22-8-21-13-7-12(18)11(17)6-10(13)16(22)25/h2-3,6-9,14,23H,4-5,19H2,1H3,(H,20,24)/b3-2+/t9-,14+/m1/s1InChI=1S/C16H18Cl2N4O3/c1-9(23)14(19)15(24)20-4-2-3-5-22-8-21-13-7-12(18)11(17)6-10(13)16(22)25/h2-3,6-9,14,23H,4-5,19H2,1H3,(H,20,24)/b3-2+/t9-,14+/m1/s1
YXMAQAPNMNRQQB-XKKUMHBKSA-NYXMAQAPNMNRQQB-XKKUMHBKSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- PDB
- Binding sites
- PF00587
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand E4O →
- PDB RCSB structure 6l2q →
- UniProt UniProt V7II86 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “E4O”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_0276.
PDB 11
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 28
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).